Additionally, as demonstrated in Supplementary Figure S16F, STAT5B expression was displayed to be positively correlated with CTL infiltration levels in endometrial carcinoma (r = 0.106, p = 1.40e−2), acute myeloid leukemia (r = 0.291, p = 1.28e−7), and triple negative breast cancer (r = 0.327, p = 3.31e−7). Here, STAT5B is linked to triple-negative breast carcinoma.